focus -WSS

focus

author：entertainment 2025-09-30 16:23:50 - browse：799

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Creating egg and sperm cells from stem cells raises ethical issues

leisure time

WSS

Gene editing the human germline: What are the risks?

Methadone treatment changes are coming. Do they go far enough?

Hilary may become 1st tropical storm to make landfall in California in 84 years

Physicians and social media: If you see something, say something?

Evacuations in place as 3 wildfires burn in eastern Washington state

Ukraine taking heavy casualties 10 weeks into its counteroffensive

entertainment

focus

leisure time

Moonlake's readout produced a cash windfall. Risks remain

Hilary expected to bring catastrophic, life

The cancer drug shortage isn’t new — and neither are the solutions

Hilary may become 1st tropical storm to make landfall in California in 84 years

Medical records are filled with copy

Baltimore teen accused of firing into crowd during block party mass shooting

Medicare details structure of new drug price negotiation program

Plastic surgeons increase patient psychiatric screenings

Novavax promises a turnaround & Lilly roils the obesity market

New details revealed about Purdue's marketing of OxyContin

explore

Listen: Racing for gene therapy & a pioneering approval

ActiGraph execs on goal of drug approvals with digital endpoints

Intermittent fasting comes with a heart risk? Not so fast

Neuroscience’s long legacy of racism

Living with Hashimoto's and celiac disease, and med school, too

ProMED sees offers of support, but its future remains unclear

hotspot

leisure time

focus

entertainment